Determinants of undergoing thyroid cancer screening in Korean women: A cross-sectional analysis from the K-Stori 2016 by 源��닔 et al.
1Cho HN, et al. BMJ Open 2019;9:e026366. doi:10.1136/bmjopen-2018-026366
Open access 
Determinants of undergoing thyroid 
cancer screening in Korean women: a 
cross-sectional analysis from the 
K-Stori 2016
Ha Na Cho,1 Eunji Choi,1 Da Hea Seo,2 Boyoung Park,  3 Sohee Park,4 Juhee Cho,5 
Sue Kim,6 Yeong-Ran Park,7 Yumie Rhee,8 Kui Son Choi1
To cite: Cho HN, Choi E, 
Seo DH, et al.  Determinants 
of undergoing thyroid cancer 
screening in Korean women: a 
cross-sectional analysis from 
the K-Stori 2016. BMJ Open 
2019;9:e026366. doi:10.1136/
bmjopen-2018-026366
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2018- 
026366).
Received 29 August 2018
Revised 2 March 2019
Accepted 5 March 2019
For numbered affiliations see 
end of article.
Correspondence to
Dr Kui Son Choi;  
 kschoi@ ncc. re. kr
Research
© Author(s) (or their 
employer(s)) 2019. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
AbstrACt
Objectives Thyroid cancer is the most common cancer 
among Korean women. Studies suggest that the incidence 
of thyroid cancer might be associated with overdiagnosis 
resulting from thyroid cancer screening. The objective of 
this study was to identify the determinants of participation 
in thyroid cancer screening in Korean women.
Methods Data were obtained from the 2016 Korean Study 
of Women’s Health-Related Issues, a nationwide cross-
sectional survey of women according to the reproductive 
life cycle. A total of 8697 cancer-free women of ages 
between 20 and 79 years were included for analysis. 
Multivariable logistic regression analysis was applied 
to analyse factors associated with adherence to thyroid 
cancer screening based on Andersen’s health behavioural 
model.
results Over the last 2 years, the rate of thyroid cancer 
screening was 39.2%. In multivariable models, older age, 
higher household income, high school education level and 
higher perceived risk of cancer were positively associated 
with thyroid cancer screening participation. Moreover, 
women who underwent cervical cancer screening 
(adjusted OR [aOR] 3.67; 95% CI 2.90 to 4.64) and breast 
cancer screening (aOR 10.91; 95% CI 8.41 to 14.14) had 
higher odds of attending thyroid cancer screening than 
women who did not attend cancer screening.
Conclusions These findings highlight the need to increase 
awareness of different recommendations on screening 
for various cancers to improve cost-effectiveness and to 
prevent unnecessary treatments.
IntrOduCtIOn 
The incidence of thyroid cancer has increased 
globally over the last three decades.1 2 
Between 1999 and 2011, the age-standardised 
rate (ASR) of thyroid cancer incidence 
in Korea increased dramatically (annual 
percentage change=22.8%).3 Although rates 
have decreased since then, about 25 209 new 
thyroid cases (11.7% of all malignancies) 
were registered in 2015: thyroid cancer (ASR, 
55.6) was the most common cancer among 
Korean women, followed by breast (ASR, 
49.2), colorectal (ASR, 22.2), stomach (ASR, 
20.5) and lung cancer (ASR, 14.3).3 Despite 
a steep increase in incidence, the age-stan-
dardised mortality rate of thyroid cancer 
remained stable, with a 5-year relative survival 
rate of 100.3%.3 
Suggestive of an epidemic, increases in 
thyroid cancer incidence in Korea have been 
deemed the results of early detection of 
small papillary thyroid cancers, which prog-
ress slowly and pose a low risk of mortality.4 
Indeed, previous studies reported that 
thyroid cancer screening rates in a region 
are strongly correlated with regional thyroid 
cancer incidence rates.5 6 The apparent 
thyroid cancer epidemic was also explained 
to be the result of increases in the incidence 
of small tumours.7 All of these studies strongly 
raised the possibility of overdiagnosis caused 
by thyroid cancer screening.
In Korea, the National Cancer Screening 
Program (NCSP), which was implemented 
strengths and limitations of this study
 ► This nationwide cross-sectional study documents 
the most recent rate of thyroid cancer screening 
among Korean women.
 ► Data were obtained from the 2016 Korean Study of 
Women’s Health-Related Issues, a population-based, 
nationwide, cross-sectional survey for a reliable and 
representative research design.
 ► Experiences of thyroid cancer screening and factors 
associated with a cancer screening were assessed 
based on Andersen’s behavioural model through 
face-to-face interviews.
 ► Due to cross-sectional study design, this study could 
not show the direction of causal relationships for 
the identified associations between thyroid cancer 
screening and other factors.
 ► More studies are needed to investigate trends in 
thyroid cancer screening rates and behaviours for 
both men and women in order to control current thy-
roid cancer epidemic issues in Korea.
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in 1999, provides nationwide screening services free 
of charge or with a small copayment for gastric, liver, 
colorectal, breast and cervical cancers.8 Although thyroid 
cancer screening is not covered under the NCSP, health-
care providers typically offer ultrasonographic screening 
for thyroid cancer as an inexpensive add-on at around 
US$30–US$50.9 In 2015, a multidisciplinary expert 
committee was organised to establish recommendations 
for thyroid cancer screening. This committee determined 
that thyroid ultrasonography screening should not be 
routinely recommended for healthy subjects, as current 
evidence with which to assess the balance of benefits 
and harms of thyroid cancer screening by ultrasonog-
raphy is insufficient.10 Through these efforts, there has 
been a marked decrease in thyroid operations. Also, the 
age-standardised incidence rates for thyroid cancer have 
decreased swiftly.3 11
Notwithstanding, the incidence of thyroid cancer in 
Korea still remains extraordinarily high, especially in 
women. Thyroid cancer is the most commonly diagnosed 
cancer in women, and incidence rates are more than 3.6 
times higher than those of men.3 Thus, public concern was 
raised concerning the potential causes of thyroid cancer, 
especially in women. However, few studies on thyroid 
cancer screening behaviours in Korea women have been 
undertaken.12 13 Thus, this study was designed to identify 
factors associated with thyroid cancer screening participa-
tion in Korean women based on Anderson’s behavioural 
model.
Anderson’s behavioural model has served as a guide in 
the selection of relevant variables with which to analyse 
determinants of the healthcare people receive since 
1968.14 The model is widely used in various settings for 
primary healthcare, general healthcare, outpatient utili-
sation and services in specific settings, such as mental and 
oral healthcare.15 This framework has also been used to 
identify factors associated with cancer screening utilisa-
tion.16–19 The model is a multilevel model that includes 
both individual factors and contextual determinants of 
healthcare use.20 According to this model, an individu-
al’s use of health services is determined by three main 
components, including predisposing factors, enabling 
factors and need factors.16 Based on previous research, 
Anderson’s behavioural model was chosen as the best 
framework for identifying the determinants of thyroid 
cancer screening attendance. Accordingly, we chose this 
model to assess thyroid cancer screening rates and to 
identify determinants of thyroid cancer screening adher-
ence in Korean women.
MAterIAls And MethOds
study population
This study was based on the Korean Study of Women’s 
Health-Related Issues (K-Stori) 2016. The K-Stori is a 
nationwide survey designed to investigate broad health 
issues among Korean women according to five stages 
in the life cycle of women (adolescence, 14–17 years; 
childbearing, 19–44 years; pregnancy and Post partum, 
19–44 years; menopause, 45–64 years and older adult-
hood, 65–79 years).21 We randomly sampled 3000 women 
in each stage of the life cycle for a reliable and representa-
tive research design. For random sampling of a multilevel, 
stratified, probability proportion, a statistics extraction 
method was used as a sampling framework using the 2010 
Population and Housing Census.
Trained interviewers from a professional research agency 
conducted door-to-door surveys to assess study eligibility. 
A total of 15 000 women aged 14–79 years completed 
in-person interview surveys (adolescents completed 
online surveys) between April 2016 and June 2016. The 
response rate of K-Stori was 40.4%. The detailed methods 
of this survey have been explained elsewhere.21 Of the 
15 000 women who participated in the K-Stori survey, we 
asked about thyroid cancer screening only for women in 
childbearing, menopause and older adulthood stages. 
We did not ask women in the adolescence and pregnancy 
and postpartum stages about thyroid cancer screening, 
because they are not appropriate for assessing cancer 
screening behaviour: women in adolescence are too 
young to assess cancer screening behaviour, and women 
in pregnancy and post partum are pregnant or have had 
a birth within less than 1 year. Thus, 6000 women in the 
adolescence and pregnancy and postpartum stages of life 
cycle were excluded. Also, 94 women aged 19 years and 
209 women who answered that they had been diagnosed 
with cancer or thyroid disease were excluded. The final 
study subjects comprised 8697 women aged 20–79 years. 
Questionnaires
Study participants were asked about their experiences 
with health examinations, including cancer screening. 
Women who answered ‘yes’ to receiving a health exam-
ination were then asked whether they had undergone 
thyroid cancer screening during the last 2 years.
Factors associated with a cancer screening were assessed 
via Andersen’s behavioural model.14 15 Final variables 
were selected from literature reviews of previous studies 
related to determinants of cancer screening.16–19 Age 
(20–29, 30–39, 40–49, 50–59, 60–69 and 70–79), marital 
status (unmarried, married, divorced/separated), family 
size (live alone, two to three, four or more people), 
education level (elementary school or less, middle/high 
school, university and higher), employment status (unem-
ployed, employed) and health screening belief (weak, 
moderate, strong) were included as predisposing factors. 
As enabling factors, we included household income 
(≤US$1699, US$1700–US$3499, ≥US$3500), private 
insurance (yes, no), residence area (urban, rural) and 
accessibility to medical services (yes, no). Finally, self-re-
ported health status (good, average, bad), perceived risk 
of cancer (low, average, high), chronic disease (yes, no) 
and other cancer screening behaviours (cervical cancer 
screening in past 2 years; breast cancer screening in past 
2 years) were considered as need factors.
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statistical analyses
X2 analysis was used to determine the statistical signifi-
cance of thyroid cancer screening behaviours according 
to variables selected as predisposing factors, enabling 
factors and need factors. Since 3000 individuals were 
sampled for each life cycle, calculating weighted cancer 
screening rate was needed based on age groups as 8697 
women aged 20–79 years were included in the study. 
Survey weighting adjustments were applied to calculate 
cancer screening rates in a representative population 
of Korean women. In addition, in multivariable logistic 
regression analysis, we applied age-adjusted weighting 
values for women in Korea. Multivariable logistic regres-
sion analysis was conducted in sequential blocks to 
analyse associations among predisposing factors, enabling 
resources and health needs in relation to thyroid cancer 
screening. Model 1 included predisposing factors only; 
model 2 added enabling factors to model 1 and model 
3 added need factors. All reported ORs were considered 
significant if p<0.05. Data were analysed using SAS V.9.3 
(SAS Institute).
Patient involvement
No patients were involved in this study.
results
Among 8697 women aged 20–79 years, 41.6% had under-
gone thyroid cancer screening within the last 2 years 
(table 1). In terms of predisposing factors, women aged 
50–59 years (58.0%), married women (48.0%), women 
with a family size of two to three members (46.3%), 
women with a middle/high school education (48.2%) 
and women who had weak belief in the effectiveness of 
health screening (43.8%) were significantly more likely 
to undergo thyroid cancer screening. Regarding enabling 
factors, women who lived in the rural area (43.9%), had 
private insurance (43.9%) and had no experiences of 
unmet healthcare needs (42.0%) were more likely to 
undergo thyroid cancer screening. In terms of need 
factors, more women who reported that their health 
status was average (45.4%), had a higher perceived risk 
of cancer (46.2%), responded as previously or currently 
having chronic diseases (48.7%) and had previously 
undergone cervical cancer screening (64.4%) or breast 
cancer screening (65.5%) attended thyroid cancer 
screening.
Within the last 2 years, the weighted thyroid cancer 
screening rate was 39.2%. Women aged 50–59 years exhib-
ited the highest rate of thyroid cancer screening (57.0%), 
whereas women aged 20–29 years held the lowest thyroid 
cancer screening rate (11.0%). Along with thyroid cancer 
screening, breast and cervical cancer screening rates 
showed similar trends according to age groups (figure 1). 
Figure 2 depicts the results of our analysis of correlations 
between thyroid cancer screening rates and other cancer 
screening rates according to age. Therein, we noted 
a strong positive correlation between thyroid cancer 
screening rate and screening for other cancers (breast: 
r=0.9558, p<0.0001, cervical: r=0.9232, p<0.0001) with 
significant results.
Table 2 lists the factors associated with thyroid cancer 
screening according to Andersen’s behavioural model. 
We conducted multivariable logistic regression analysis 
with predisposing factors only in model 1, with the addi-
tion of enabling factors in model 2, and with the addi-
tion of need factors in model 3. In model 1, compared 
with women of ages 40–49 years, those aged less than 
40 years were less likely to undergo thyroid cancer 
screening (20–29: adjusted OR [aOR] 0.26; 95% CI 0.19 
to 0.35, 30–39: aOR 0.58; 95% CI 0.47 to 0.71), whereas 
women older than 50 years were more likely to undergo 
thyroid cancer screening (aOR 1.78; 95% CI 1.48 to 
2.13). Married women had the highest odds of under-
going thyroid cancer screening, compared with women 
who were not married (aOR 1.74; 95% CI 1.33 to 2.29). 
Women with higher education showed increased odds of 
attending thyroid cancer screening (middle/high school: 
aOR 1.22; 95% CI 1.05 to 1.43, university and higher: 
aOR 1.26; 95% CI 1.02 to 1.55). Interestingly, women 
who had a strong belief in the effectiveness of health 
screening had lower odds of attending thyroid cancer 
screening than women with weak belief (aOR 0.79; 95% 
CI 0.68 to 0.91). Employed women were more likely to 
undergo thyroid cancer screening than those who were 
unemployed (aOR 1.19; 95% CI 1.05 to 1.34).
In model 2, in which we added enabling factors to 
model 1, age group, marital status and belief in the effec-
tiveness of health screening showed similar results to 
those attained in model 1. Meanwhile, larger family size 
additionally showed a negative association with attending 
thyroid cancer screening. Regarding enabling factors, 
women with a household income equal to or more than 
US$3500 had higher odds of attending thyroid cancer 
screening than women with income equal to or less than 
US$1699 (aOR 1.55; 95% CI 1.28 to 1.89). Women who 
had private insurance had higher odds of attending 
thyroid cancer screening than women who did not have 
private insurance (aOR 1.45; 95% CI 1.24 to 1.69). An 
experience of an unmet healthcare need did not signifi-
cantly alter results (aOR 0.99; 95% CI 0.81 to 1.21).
In model 3, after adding need factors to model 2, women 
of ages of 50–59 (aOR 1.58; 95% CI 1.28 to 1.94), 60–69 
(aOR 1.64; 95% CI 1.27 to 2.10) and 70–79 (aOR 2.27; 
95% CI 1.68 to 3.07) years were significantly more likely 
to undergo thyroid cancer screening, compared with 
women aged 40–49 years. Women who had a middle or 
high school education, moderate belief in the effective-
ness of health screening, household income equal to or 
more than US$3500, and higher perceived risk of cancer 
were more likely to attend thyroid cancer. Attending breast 
or cervical cancer screening was the strongest predictor 
for undergoing thyroid cancer screening. Women who 
attended cervical cancer screening (aOR 3.67; 95% CI 
2.90 to 4.64) and breast cancer screening (aOR 10.91; 95% 
CI 8.41 to 14.14) had higher odds of attending thyroid 
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Table 1 Characteristics of the study subjects according to receipt of thyroid cancer screening within 2 years (n=8697)
Total N (%)
Unweighted, N (%) Weighted, %
P value*No Yes Yes
Total 8697 (100) 5082 (58.4) 3615 (41.6) 39.2
Predisposing
Age group <0.0001
  20–29 1210 (13.9) 1085 (89.7) 125 (10.3) 11.0
  30–39 1182 (13.6) 857 (72.5) 325 (27.5) 28.5
  40–49 1217 (14.0) 664 (54.6) 553 (45.4) 43.0
  50–59 1456 (16.7) 611 (42.0) 845 (58.0) 57.0
  60–69 1703 (19.6) 799 (46.9) 904 (53.1) 51.8
  70–79 1929 (22.2) 1066 (55.3) 863 (44.7) 45.0
Marital status <0.0001
  Unmarried 1445 (16.6) 1265 (87.5) 180 (12.5) 13.9
  Married 5892 (67.8) 3066 (52.0) 2826 (48.0) 46.7
  Divorced/widowed/separated 1360 (15.6) 751 (55.2) 609 (44.8) 45.4
Family size
  Live alone 872 (10.0) 512 (58.7) 360 (41.3) 40.0 <0.0001
  2–3 4004 (46.0) 2150 (53.7) 1854 (46.3) 43.5
  4 or more 3821 (43.9) 2420 (63.3) 1401 (36.7) 36.2
Education level <0.0001
  Elementary school or less 1846 (21.2) 1013 (54.9) 833 (45.1) 45.3
  Middle/high school 3964 (45.6) 2052 (51.8) 1912 (48.2) 46.3
  University and higher 2887 (33.2) 2017 (69.9) 870 (30.1) 30.5
Employment status 0.7695
  Unemployed 4757 (54.7) 2773 (58.3) 1984 (41.7) 39.1
  Employed 3940 (45.3) 2309 (58.6) 1631 (41.4) 39.3
Belief in health screening effectiveness 0.0003
  Weak 4233 (48.7) 2381 (56.3) 1852 (43.8) 40.8
  Moderate 2872 (33.0) 1737 (60.5) 1135 (39.5) 39.1
  Strong 1592 (18.3) 964 (60.6) 628 (39.5) 35.8
Enabling
Monthly household income (US$) 0.1553
  ≤1699 2246 (25.8) 1275 (56.8) 971 (43.2) 41.0
  1700–3499 3518 (40.5) 2066 (58.7) 1452 (41.3) 38.4
  ≥3500 2933 (33.7) 1741 (59.4) 1192 (40.6) 39.5
Urbanisation 0.0249
  Urban 6911 (79.5) 4080 (59.0) 2831 (41.0) 38.8
  Rural 1786 (20.5) 1002 (56.1) 784 (43.9) 41.6
Private insurance
  No 2468 (28.4) 1589 (64.4) 879 (35.6) 33.3 <0.0001
  Yes 6229 (71.6) 3493 (56.1) 2736 (43.9) 40.8
Experience of unmet healthcare need
  Yes 837 (9.6) 519 (62.0) 318 (38.0) 39.2 0.0274
  No 7860 (90.4) 4563 (58.0) 3297 (42.0) 39.5
Need
Self-reported health status <0.0001
  Good 4546 (52.3) 2801 (61.6) 1745 (38.4) 36.4
  Average 2860 (32.9) 1561 (54.6) 1299 (45.4) 43.4
  Bad 1291 (18.4) 720 (55.8) 571 (44.2) 43.5
Continued
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cancer screening than women who had not undergone 
screening for either of these other cancers.
dIsCussIOn
This study examined recent thyroid cancer screening 
rates and factors associated with thyroid cancer screening 
over the last 2 years for women aged 20–79 years according 
to Andersen’s behavioural model. Even though Korean 
cancer guidelines do not recommend thyroid cancer 
screening for asymptomatic individuals, the weighted rate 
of thyroid cancer screening among women was 39.2%, 
which the highest it has been in Korea. Thyroid cancer 
screening rates for women were reported at 16.4% by 
the National Cancer Screening Survey in 2009, at 16% 
by the Korean Community Health Survey in 2010 and 
at 31.3% by the National Evidence-Based Healthcare 
Collaborating Agency in 2011.6 12 13 These three studies 
were all nationwide surveys, although they used different 
questionnaires, age ranges and screening intervals. Due 
to these differences, we could not confirm an increase in 
thyroid cancer screening rates by comparing our results 
with previous studies. However, it can be inferred that the 
rate of screening has increased.
Studies in Korea are reporting correlations between 
increased incidences of and screening rates for thyroid 
cancer.7 9 In the present study, we noted that more than 
Total N (%)
Unweighted, N (%) Weighted, %
P value*No Yes Yes
Perceived risk of cancer <0.0001
  Low 2840 (32.7) 1887 (66.4) 953 (33.6) 31.7
  Average 3378 (33.9) 1861 (55.1) 1517 (44.9) 42.4
  High 2479 (28.5) 1334 (53.8) 1145 (46.2) 44.5
Chronic disease <0.0001
  Yes 2568 (29.5) 1317 (51.3) 1251 (48.7) 49.5
  No 6129 (70.5) 3765 (61.4) 2364 (38.6) 36.7
Cervical cancer screening in past 2 years <0.0001
  No 3678 (42.3) 3297 (89.6) 381 (10.4) 7.7
  Yes 5019 (57.7) 1785 (35.6) 3234 (64.4) 63.6
Breast cancer screening in past 2 years <0.0001
  No 3599 (41.4) 3324 (92.4) 275 (7.6) 5.7
  Yes 5098 (58.6) 1758 (34.5) 3340 (65.5) 65.7
*P value for unweighted thyroid cancer screening rates.
Table 1 Continued 
Figure 1 Weighted cancer screening rates for three types of cancer according to age groups.
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half of women aged 50–59 (57.0%) and 60–69 (51.8%) 
years attended thyroid cancer screening over the last 
2 years. Consistent with these results, previous studies 
have also indicated that women aged 50–59 years exhibit 
the highest thyroid cancer screening rate.12 22 Meanwhile, 
the age-specific incidence of thyroid cancer in 2013 
peaked in Korean women aged 50–59 years.7 Addition-
ally, when we compared thyroid cancer incidence in data 
from the Korean Central Cancer Registry in 2014 and 
thyroid cancer screening rates from our study, we noted 
strong correlations between them (online supplementary 
1). These results support the association between thyroid 
cancer incidence and thyroid cancer screening. Indeed, 
many hospitals and clinicians in Korea encourage routine 
health checks that include the option of screening for 
thyroid cancer (for an additional fee, as this is not covered 
by national health insurance).6 7
As factors associated with thyroid cancer screening 
in multivariable logistic regression analysis, women 
with older age, middle or high school education level, 
moderate belief in health screening effectiveness, house-
hold income equal to or more than US$3500, average or 
high levels of perceived risk of cancer and prior experi-
ence with breast or cervical cancer screening were more 
likely to undergo thyroid cancer screening. Women who 
attended cervical cancer screening (aOR 3.67; 95% CI 
2.90 to 4.64) or breast cancer screening (aOR 10.91; 
95% CI 8.41 to 14.14) had higher odds of attending 
thyroid cancer screening than women who did not attend 
cancer screening. Our results are similar to those in 
previous studies on the association between participa-
tion in screening for other cancers and thyroid cancer 
screening.12 13 In particular, it has been reported that 
women who have undergone breast cancer screening are 
prone to undergo thyroid cancer screening.17 18
With the promotion of cancer screening by the govern-
ment and media, participation rates in the NCSP have 
increased dramatically over the last two decades.8 23 
Although thyroid cancer screening is not included in the 
NCSP, the rate of screening for thyroid cancer seems 
to have been affected by the NCSP. In general, people 
who participate the NCSP can receive thyroid cancer 
screening additionally based on their own needs or their 
physician’s recommendations by paying an extra fee. 
In support of this notion, researchers reported that, in 
Korea, the incidence of thyroid cancer increased slowly 
beginning in 1990; however, after the NCSP was launched 
for gastric, breast, cervical, liver and colorectal cancer, it 
rapidly increased.8 According to cancer statistics, the inci-
dence of thyroid cancer in 2011 was 15-fold higher than 
that in 1993.9
In recent decades, the incidence of thyroid cancer 
has increased steadily and consistently in many devel-
oped countries. According to a recently reported article, 
the highest rates (>25 cases per 100 000 women) were 
observed in Korea, Israel, Canada, USA, Italy, France and 
low-income and middle-income countries (LMICs), such 
as Turkey, Costa Rica, Brazil and Ecuador.24 This interna-
tional comparison study confirmed the very high thyroid 
cancer incidence rates in some, but not all, high-income 
countries in 2008–2012 and also showed very high inci-
dence rates in several LMICs, particularly in urban areas.24 
The very high thyroid cancer incidence and low mortality 
rates in some LMICs also strongly suggest a major role 
for overdiagnosis. Ultrasound examinations have become 
increasingly available, and encouraging opportunistic 
screening has increased detection of smaller, asymptom-
atic nodules. Overdiagnosis is more likely to occur under 
privately oriented healthcare systems in the absence of a 
gatekeeping role in primary care for referral to secondary 
care and under systems where doctors are paid by a fee 
for service. Also, the absence of thyroid cancer screening 
guidelines may contribute diagnosis of indolent tumours. 
Thus, special concern is needed for these countries to 
reduce overdiagnosis.
Figure 2 Correlations between thyroid cancer screening rate and (A) breast and (B) cervical cancer screening rate according to 
age (a year). Each dot represents age.
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Table 2 Associations among predisposing, enabling and need factors in relation to thyroid cancer screening within the last 2 
years (n=8697)
Model 1 Model 2 Model 3
aOR 95% CI aOR 95% CI aOR 95% CI
Predisposing
Age group
  20–29 0.26 (0.19 to 0.35) 0.26 (0.19 to 0.37) 0.71 (0.51 to 1.01)
  30–39 0.58 (0.47 to 0.71) 0.60 (0.48 to 0.73) 1.01 (0.79 to 1.28)
  40–49 1.00 1.00 1.00
  50–59 1.78 (1.48 to 2.13) 1.74 (1.45 to 2.09) 1.58 (1.28 to 1.94)
  60–69 1.53 (1.25 to 1.88) 1.62 (1.32 to 1.98) 1.64 (1.27 to 2.10)
  70–79 1.30 (1.04 to 1.62) 1.51 (1.19 to 1.90) 2.27 (1.68 to 3.07)
Marital status
  Unmarried 1.00 1.00 1.00
  Divorced/widowed/separated 1.52 (1.10 to 2.11) 1.58 (1.14 to 2.21) 1.07 (0.74 to 1.55)
  Married 1.74 (1.33 to 2.29) 1.73 (1.31 to 2.28) 0.88 (0.65 to 1.20)
Family size
  Live alone 1.00 1.00 1.00
  2–3 0.81 (0.62 to 1.07) 0.74 (0.55 to 0.98) 0.93 (0.69 to 1.25)
  4 and more 0.78 (0.58 to 1.03) 0.66 (0.48 to 0.89) 0.85 (0.62 to 1.17)
Education
  Elementary school or less 1.00 1.00 1.00
  Middle/high school 1.22 (1.05 to 1.43) 1.07 (0.91 to 1.26) 1.28 (1.02 to 1.59)
  University and higher 1.26 (1.02 to 1.55) 0.99 (0.80 to 1.24) 1.27 (0.96 to 1.68)
Employment status
  Unemployed 1.00 1.00 1.00
  Employed 1.19 (1.05 to 1.34) 1.1 (0.97 to 1.24) 0.91 (0.79 to 1.06)
Belief of health screening effectiveness
  Weak 1.00 1.00 1.00
  Moderate 0.99 (0.87 to 1.12) 1.00 (0.87 to 1.13) 1.25 (1.07 to 1.45)
  Strong 0.79 (0.68 to 0.91) 0.80 (0.69 to 0.92) 1.14 (0.94 to 1.38)
Enabling
Monthly household income (US$)
  ≤1699 1.00 1.00
  1700–3499 1.16 (0.98 to 1.37) 1.23 (0.99 to 1.51)
  ≥3500 1.55 (1.28 to 1.89) 1.44 (1.13 to 1.84)
Urbanisation
  Rural 1.00 1.00
  Urban 0.88 (0.77 to 1.01) 0.95 (0.81 to 1.12)
Private insurance
  No 1.00 1.00
  Yes 1.45 (1.24 to 1.69) 1.17 (0.96 to 1.42)
Experience of unmet healthcare need
  Yes 1.00 1.00
  No 0.99 (0.81 to 1.21) 0.93 (0.74 to 1.16)
Need
Self-reported health status
  Good 1.00
  Average 0.84 (0.65 to 1.09)
  Bad 0.96 (0.82 to 1.12)
Continued
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In previous studies, socioeconomic status was identified as 
a significant risk factor affecting the prevalence of thyroid 
cancer.22 25 In one of these studies, women with higher levels 
of household income were found to have attended thyroid 
cancer screening more.25 This is consistent with our study. 
In Korea, thyroid cancer screening is provided via oppor-
tunistic screening,13 and opportunistic screening is more 
commonly used by people with higher income in Korea.26 
Meanwhile, we also found perceived risk of cancer to be a 
significant factor in thyroid cancer screening attendance. 
While there are no studies related to perceived cancer 
risk and thyroid cancer screening, a significant association 
between breast cancer risk and mammography has been 
reported.27 We suspect that recent reports of steep increases 
in thyroid cancer incidence may have increased fears and 
perceived risk of thyroid cancer.
The current study reports the most recent thyroid cancer 
screening rate and factors associated therewith in women 
using data from a nationwide survey. This was the first 
study to focus on women’s health-related issues concerning 
thyroid cancer screening. However, there are some limita-
tions to this study. Due to the cross-sectional study design, 
this study could not show the direction of causal relation-
ships for the identified associations between thyroid cancer 
screening and other factors. Also, information on thyroid 
cancer screening and other independent variables could 
contribute to recall bias because the data were obtained 
from a self-reported survey (K-Stori). Previous research has 
shown that screening rates from self-reported surveys can 
be under or overestimated depending on individual char-
acteristics.28 29 Notwithstanding, the survey was conducted 
by trained interviewers, and professional research agen-
cies provided quality control for interviewers and ensured 
missing values and data errors were minimal.
Although this study reports current thyroid cancer 
screening rates and factors associated therewith, further 
studies are needed to investigate and to control current 
thyroid cancer epidemic issues in Korea. In particular, 
since the National Cancer Screening Guidelines only 
recently announced that thyroid cancer screening is not 
recommended in asymptomatic adults, it is necessary to 
assess changes in thyroid cancer screening behaviour as 
a result thereof. Also, further study is needed to deter-
mine potential causes of thyroid cancer and thyroid 
cancer screening behaviour for both men and women.
COnClusIOns
In conclusion, even though thyroid cancer screening is 
not recommended for asymptomatic populations, about 
40% of Korean women attended thyroid cancer screening 
over the last 2 years. Women who attended breast or 
cervical cancer, which are nationally recommended for 
Korean women, were more likely to attend thyroid cancer 
screening. These findings highlight the need to increase 
awareness of different recommendations for various 
cancer screenings in order to minimise poor cost-effec-
tiveness and risk of overdiagnosis. Increasing awareness 
of the benefits and risks of thyroid cancer screening may 
require targeted intervention.
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